Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis
SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs. 1 Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a pred...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 1980-12, Vol.303 (24), p.1400-1404 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1404 |
---|---|
container_issue | 24 |
container_start_page | 1400 |
container_title | The New England journal of medicine |
container_volume | 303 |
creator | Roberts, L. Jackson Sweetman, Brian J Lewis, Robert A Austen, K. Frank Oates, John A |
description | SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs.
1
Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock.
Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder.
2
,
3
After the recent demonstration that combined . . . |
doi_str_mv | 10.1056/NEJM198012113032405 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75328140</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4315264271</sourcerecordid><originalsourceid>FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</originalsourceid><addsrcrecordid>eNp9UE1Lw0AQXUSptfoLRAgIXiS6s985Sq1aaW1BPYft7kZTmkSzG6T_3i0tHkScwwzDe_N48xA6BXwFmIvrp9HjFDKFgQBQTAnDfA_1gVOaMobFPupjTFTKZEYP0ZH3SxwLWNZDPQFYKk76aDauTeu0dzaZt43tTCibOmmKzeaDflvp2pZ1ckuS2Oc6lK4OPvkqw3vyvPbBVaVJptqHxqxD40t_jA4KvfLuZDcH6PVu9DJ8SCez-_HwZpIaKlhIpSuU1XhBnSGcY2sKLLkWkgJTTkiriAYLxhEq7MLRjBVANJURNAYKtSADdLHV_Wibz875kFelN24V_bqm87nklChgOBLPfxGXTdfW0VsOSmRcUalYZNEty8S3feuK_KMtK92uc8D5Juz8j7Dj1dlOu1tUzv7c7NKN-OUWryqf125Z_av2DauAhaA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1869583784</pqid></control><display><type>article</type><title>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</title><source>MEDLINE</source><creator>Roberts, L. Jackson ; Sweetman, Brian J ; Lewis, Robert A ; Austen, K. Frank ; Oates, John A</creator><creatorcontrib>Roberts, L. Jackson ; Sweetman, Brian J ; Lewis, Robert A ; Austen, K. Frank ; Oates, John A</creatorcontrib><description>SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs.
1
Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock.
Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder.
2
,
3
After the recent demonstration that combined . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198012113032405</identifier><identifier>PMID: 6107852</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Acids ; Adult ; Animals ; Aspirin - administration & dosage ; Aspirin - therapeutic use ; Biopsy ; Cardiac arrhythmia ; Case reports ; Chromatography ; Dyspnea ; Female ; Histamine ; Histamine H1 Antagonists - therapeutic use ; Histamine H2 Antagonists - therapeutic use ; Humans ; Male ; Mast Cells - metabolism ; Mastocytosis ; Middle Aged ; Pathogenesis ; Patients ; Primates ; Prostaglandin D2 ; Prostaglandins - biosynthesis ; Prostaglandins D - biosynthesis ; Prostaglandins D - urine ; Pruritus ; Retention ; Urine ; Urticaria Pigmentosa - drug therapy ; Urticaria Pigmentosa - metabolism ; Urticaria Pigmentosa - physiopathology</subject><ispartof>The New England journal of medicine, 1980-12, Vol.303 (24), p.1400-1404</ispartof><rights>Copyright Massachusetts Medical Society Dec 11, 1980</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</citedby><cites>FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</cites></display><links><openurl>$$Topenurl_article</openurl><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6107852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roberts, L. Jackson</creatorcontrib><creatorcontrib>Sweetman, Brian J</creatorcontrib><creatorcontrib>Lewis, Robert A</creatorcontrib><creatorcontrib>Austen, K. Frank</creatorcontrib><creatorcontrib>Oates, John A</creatorcontrib><title>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs.
1
Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock.
Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder.
2
,
3
After the recent demonstration that combined . . .</description><subject>Acids</subject><subject>Adult</subject><subject>Animals</subject><subject>Aspirin - administration & dosage</subject><subject>Aspirin - therapeutic use</subject><subject>Biopsy</subject><subject>Cardiac arrhythmia</subject><subject>Case reports</subject><subject>Chromatography</subject><subject>Dyspnea</subject><subject>Female</subject><subject>Histamine</subject><subject>Histamine H1 Antagonists - therapeutic use</subject><subject>Histamine H2 Antagonists - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Mast Cells - metabolism</subject><subject>Mastocytosis</subject><subject>Middle Aged</subject><subject>Pathogenesis</subject><subject>Patients</subject><subject>Primates</subject><subject>Prostaglandin D2</subject><subject>Prostaglandins - biosynthesis</subject><subject>Prostaglandins D - biosynthesis</subject><subject>Prostaglandins D - urine</subject><subject>Pruritus</subject><subject>Retention</subject><subject>Urine</subject><subject>Urticaria Pigmentosa - drug therapy</subject><subject>Urticaria Pigmentosa - metabolism</subject><subject>Urticaria Pigmentosa - physiopathology</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>false</fulltext><rsrctype>article</rsrctype><creationdate>1980</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9UE1Lw0AQXUSptfoLRAgIXiS6s985Sq1aaW1BPYft7kZTmkSzG6T_3i0tHkScwwzDe_N48xA6BXwFmIvrp9HjFDKFgQBQTAnDfA_1gVOaMobFPupjTFTKZEYP0ZH3SxwLWNZDPQFYKk76aDauTeu0dzaZt43tTCibOmmKzeaDflvp2pZ1ckuS2Oc6lK4OPvkqw3vyvPbBVaVJptqHxqxD40t_jA4KvfLuZDcH6PVu9DJ8SCez-_HwZpIaKlhIpSuU1XhBnSGcY2sKLLkWkgJTTkiriAYLxhEq7MLRjBVANJURNAYKtSADdLHV_Wibz875kFelN24V_bqm87nklChgOBLPfxGXTdfW0VsOSmRcUalYZNEty8S3feuK_KMtK92uc8D5Juz8j7Dj1dlOu1tUzv7c7NKN-OUWryqf125Z_av2DauAhaA</recordid><startdate>19801211</startdate><enddate>19801211</enddate><creator>Roberts, L. Jackson</creator><creator>Sweetman, Brian J</creator><creator>Lewis, Robert A</creator><creator>Austen, K. Frank</creator><creator>Oates, John A</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19801211</creationdate><title>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</title><author>Roberts, L. Jackson ; Sweetman, Brian J ; Lewis, Robert A ; Austen, K. Frank ; Oates, John A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c364t-7ef8da0b3ec2550dcf075a673148e67d82a1d1ce236dbe394f12a3748ecc1f8b2</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1980</creationdate><topic>Acids</topic><topic>Adult</topic><topic>Animals</topic><topic>Aspirin - administration & dosage</topic><topic>Aspirin - therapeutic use</topic><topic>Biopsy</topic><topic>Cardiac arrhythmia</topic><topic>Case reports</topic><topic>Chromatography</topic><topic>Dyspnea</topic><topic>Female</topic><topic>Histamine</topic><topic>Histamine H1 Antagonists - therapeutic use</topic><topic>Histamine H2 Antagonists - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Mast Cells - metabolism</topic><topic>Mastocytosis</topic><topic>Middle Aged</topic><topic>Pathogenesis</topic><topic>Patients</topic><topic>Primates</topic><topic>Prostaglandin D2</topic><topic>Prostaglandins - biosynthesis</topic><topic>Prostaglandins D - biosynthesis</topic><topic>Prostaglandins D - urine</topic><topic>Pruritus</topic><topic>Retention</topic><topic>Urine</topic><topic>Urticaria Pigmentosa - drug therapy</topic><topic>Urticaria Pigmentosa - metabolism</topic><topic>Urticaria Pigmentosa - physiopathology</topic><toplevel>peer_reviewed</toplevel><creatorcontrib>Roberts, L. Jackson</creatorcontrib><creatorcontrib>Sweetman, Brian J</creatorcontrib><creatorcontrib>Lewis, Robert A</creatorcontrib><creatorcontrib>Austen, K. Frank</creatorcontrib><creatorcontrib>Oates, John A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>no_fulltext</fulltext></delivery><addata><au>Roberts, L. Jackson</au><au>Sweetman, Brian J</au><au>Lewis, Robert A</au><au>Austen, K. Frank</au><au>Oates, John A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1980-12-11</date><risdate>1980</risdate><volume>303</volume><issue>24</issue><spage>1400</spage><epage>1404</epage><pages>1400-1404</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>SYSTEMIC mastocytosis is a disorder of unknown origin, characterized by abnormal proliferation of tissue mast cells involving various organs and associated with a variety of clinical symptoms and signs.
1
Episodic attacks of flushing, frequently accompanied by hypotension and tachycardia, are a predominant manifestation of systemic mastocytosis, which at times can result in life-threatening shock.
Although the symptoms of mastocytosis have generally been attributed to the release of histamine from mast cells, only partial amelioration of symptoms has been described in the few isolated case reports on the effects of histamine-antagonist therapy of this disorder.
2
,
3
After the recent demonstration that combined . . .</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>6107852</pmid><doi>10.1056/NEJM198012113032405</doi><tpages>5</tpages></addata></record> |
fulltext | no_fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 1980-12, Vol.303 (24), p.1400-1404 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_75328140 |
source | MEDLINE |
subjects | Acids Adult Animals Aspirin - administration & dosage Aspirin - therapeutic use Biopsy Cardiac arrhythmia Case reports Chromatography Dyspnea Female Histamine Histamine H1 Antagonists - therapeutic use Histamine H2 Antagonists - therapeutic use Humans Male Mast Cells - metabolism Mastocytosis Middle Aged Pathogenesis Patients Primates Prostaglandin D2 Prostaglandins - biosynthesis Prostaglandins D - biosynthesis Prostaglandins D - urine Pruritus Retention Urine Urticaria Pigmentosa - drug therapy Urticaria Pigmentosa - metabolism Urticaria Pigmentosa - physiopathology |
title | Increased Production of Prostaglandin D2 in Patients with Systemic Mastocytosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A25%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20Production%20of%20Prostaglandin%20D2%20in%20Patients%20with%20Systemic%20Mastocytosis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Roberts,%20L.%20Jackson&rft.date=1980-12-11&rft.volume=303&rft.issue=24&rft.spage=1400&rft.epage=1404&rft.pages=1400-1404&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJM198012113032405&rft_dat=%3Cproquest_cross%3E4315264271%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1869583784&rft_id=info:pmid/6107852&rfr_iscdi=true |